glp-1 novo nordisk products Lilly, Sink on FDA List of Foreign Ingredient Makers Company of the Year 2024:

A valuable framework for clinicians moving forward Clinical Assistant Professor of Medicine, Division of Endocrinology , Diplomate of American Board of Obesity Medicine Newly published treatment algorithm for the pharmacologic treatment of obesity and its complications, from the European Association for the Study of Obesity (EASO) Semaglutide and tirzepatide are recommended as first line to treat obesity AND to treat underlying obesity-related complications

Cardioprotection / cytoprotection Researched in animal studies for possible cytoprotective effects on cardiac and other tissue

Liposomal vitamin C protects vitamin C during digestion and supports better delivery to the bloodstream

Tambini also outlined the potential risks of these supplements including inconsistent dosages, hidden or harmful ingredients, and the possibility of interfering with other medications